|
|
Press Releases
| All Releases |
|---|
 |
Osiris Therapeutics Reports Second Quarter 2007 Financial Results
08-09-07
18.0 KB
|
| |
COLUMBIA, Md., Aug 09, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today its results for the second quarter ended June 30, 2007.
Highlights for ...
|
|
Osiris Announces Second Quarter 2007 Financial Results Conference Call
08-06-07
9.6 KB
|
| |
COLUMBIA, Md., Aug 06, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that it will report its financial results for the quarter ended June 30, 2...
|
|
Osiris Therapeutics, Inc. (OSIR) Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell
08-01-07
10.4 KB
|
| |
ADVISORY, Aug 1, 2007 (PrimeNewswire via COMTEX News Network) --
What:
C. Randal Mills, Ph.D., President and Chief Executive Officer of
Osiris Therapeutics, Inc. (Nasdaq:OSIR) will preside over the
closing bell.
Where:
NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
When:
Friday, August 3, 2007 at 4 ...
|
|
Osiris and Genzyme Partner to Develop Medical Countermeasures for Nuclear and Radiological Threats
07-26-07
14.6 KB
|
| |
COLUMBIA, Md., Jul 26, 2007 (BUSINESS WIRE) -- Osiris Therapeutics (NASDAQ:OSIR) and Genzyme Corp. (NASDAQ:GENZ) today announced the formation of a partnership to address the significant need for effective countermeasures to nuclear terrorism and other radiological emergencies. The initial focus of the partnership will be to develop Prochymal(TM), ...
|
|
Osiris Therapeutics to Present at Jefferies Healthcare Conference
06-22-07
8.8 KB
|
| |
BALTIMORE, Jun 22, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company, announced today that C. Randal Mills, Ph.D., President and CEO, will present at the Jefferies Healthcare Conference in New York. Dr. Mills is scheduled to present at 4:40 pm ET on June 27, 2007. A live audio webcast may be ac...
|
|
Osiris Therapeutics Announces $20 Million Private Placement
06-06-07
11.5 KB
|
| |
BALTIMORE, Jun 06, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company announced today that it had priced a private placement of its common stock through the efforts of Friedli Corporate Finance, Inc. of Switzerland. The Company agreed to sell 1,757,469 shares, or $20 million, of its common stock...
|
|
Osiris Therapeutics Added to NASDAQ Biotechnology Index
05-14-07
9.0 KB
|
| |
BALTIMORE, May 14, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that it has been selected for addition to the NASDAQ Biotechnology Index(R), e...
|
|
Osiris Therapeutics Reports First Quarter 2007 Financial Results
05-14-07
17.9 KB
|
| |
BALTIMORE, May 14, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today its results for the first quarter ended March 31, 2007.
First Quarter Highl...
|
|
Osiris Announces First Quarter 2007 Financial Results Conference Call
05-09-07
9.6 KB
|
| |
BALTIMORE, May 09, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that it will report its financial results for the quarter ended March 31, 2007...
|
|
Osiris Named Biotechnology Company of the Year
05-03-07
9.2 KB
|
| |
BALTIMORE, May 03, 2007 (BUSINESS WIRE) -- Osiris Therapeutics, Inc. (Nasdaq:OSIR) announced today that it has been awarded "Biotechnology Firm of the Year" by the Technology Council of Maryland. Over 900 business and government leaders were in attendance at the Council's 2007 Annual Tech Awards Celebration held on May 2, 2007. C. Randal Mills, Ph....
|
|
|
 |
Stock Information
OSIR - (NASDAQ)
$6.57
+ 0.09
|
11-20-09
4:11 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
|
|
|
|
|
Shareholder Tools
|
|
